Overview
Details
Chat
Can pharmaceutical stocks still benefit from the fluctuating pandemic situation?
Live streaming time: 29/03/2022 12:00
Amidst the rampant global outbreak of COVID-19 in recent years, the epidemic has continued to fluctuate in 2022. Is there still a good opportunity for pharmaceutical stocks to absorb? Will COVID-19 concept stocks be able to break out from the pharmaceutical sector? Cat, the popular stock market expert, takes you on a tour of the entire pharmaceutical industry investment opportunities! 🤳Live broadcast highlights: 1. Big break-up of the pharmaceutical industry chain; 2. Are COVID-19 concept stocks and vaccine stocks still worth investing in?
Live Assistant
Risk and Disclaimer Statement:
The content on this page reflects the personal opinion of the author and is intended solely as general information for your reference. It shall not be construed as advice or a basis for any specific investment, business, or commercial decisions. The views expressed in the content do not represent any position of LongPort or any investment recommendations or endorsements related to LongPort. LongPort does not make any guarantee or commitment to the truthfulness, accuracy, or originality of the content. Investors should analyze the risks related to the investment based on their own circumstances and seek advice from a professional investment advisor when necessary.